Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Muscular Dystrophy Association, Inc.
*STREET
222 S. Riverside Plaza, Suite 1500
*CITY
Chicago
*STATE
(Required for U.S. applicants)
Illinois
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
60606
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Illinois
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
009
*IDENTIFICATION
Computer software and mobile applications for collecting, managing, and analyzing data related to patient registries in the field of
neuromuscular diseases
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
035
*IDENTIFICATION
Maintaining a registry of information about neuromuscular diseases; Maintaining a registry of national and international databases in the
field of neuromuscular diseases; Maintaining a registry of de-identified clinical and patient data in the field of neuromuscular disease research; recruitment of participants for clinical research;
maintaining a registry of participants for clinical research relating to the treatment and research of neuromuscular diseases
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
035
*IDENTIFICATION
Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of neuromuscular disease
research; Promoting public awareness of neuromuscular diseases; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the
field of neuromuscular diseases; promoting participation in clinical trials and research in the field of neuromuscular diseases
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88049969
Filing Date:07/24/2018
To the Commissioner for Trademarks:
MARK: MOVR (Standard Characters, see mark)
The literal element of the mark consists of MOVR.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Muscular Dystrophy Association, Inc., a corporation of Illinois, having an address of
222 S. Riverside Plaza, Suite 1500
Chicago, Illinois 60606
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 009: Computer software and mobile applications for collecting, managing, and analyzing data related to patient registries in the field
of neuromuscular diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 035: Maintaining a registry of information about neuromuscular diseases; Maintaining a registry of national and international databases
in the field of neuromuscular diseases; Maintaining a registry of de-identified clinical and patient data in the field of neuromuscular disease research; recruitment of participants for clinical
research; maintaining a registry of participants for clinical research relating to the treatment and research of neuromuscular diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 035: Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of neuromuscular
disease research; Promoting public awareness of neuromuscular diseases; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances
in the field of neuromuscular diseases; promoting participation in clinical trials and research in the field of neuromuscular diseases
In International Class 035, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 03/10/2018, and first used in
commerce at least as early as 03/10/2018, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) March 2018 print advertisement and screenshot from Applicant's website showing use of mark..
International Class 044: Providing health, medical, pharmaceutical, health management and disease management information to others
In International Class 044, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 03/10/2018, and first used in
commerce at least as early as 03/10/2018, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) Screenshot from Applicant's website showing use of the mark..
The applicant's current Attorney Information:
Melanie J. Howard and All Authorized Attorneys of Loeb & Loeb LLP of Loeb & Loeb LLP 10100 Santa Monica Blvd., Suite
2200
Los Angeles, California 90067
United States
trademarks@loeb.com (authorized)
The attorney docket/reference number is 230616-00002.
The applicant's current Correspondence Information:
Melanie J. Howard
Loeb & Loeb LLP
10100 Santa Monica Blvd., Suite 2200
Los Angeles, California 90067
trademarks@loeb.com;mhoward@loeb.com; scrisafulli@loeb.com; mhazel@loeb.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).